current endoscopic treatment of dysphonia目前言语障碍的内镜治疗.pdfVIP

Diagnostic and Therapeutic Endoscopy, Vol. 6, pp. 87-90 (C) 2000 OPA (Overseas Publishers Association) N.V. Reprints available directly from the publisher Published by license under Photocopying permitted by license only the Harwood Academic Publishers imprint, part of The Gordon and Breach Publishing Group. Printed in Malaysia. Current Endoscopic Treatment of Dysphonia JOHN M. SCHWEINFURTH* and ROBERT H. OSSOFF Department of Otolaryngology, Vanderbilt University, MCN S-2100, Nashville, TN 37232-2559, USA (Received30 July 1999, Revised 20 September 1999; In final form 1 October 1999) Benign laryngeal disorders result in dysphonia because of effects on glottic closure and the vibratory characteristics of the true vocal fold. Treatment is initially directed at reversing medical conditions andpatterns of abuse with surgery reserved for unresolving lesions result- ing in troublesome dysphonia. Benign lesions that require surgery are excised as precisely as possible sparing overlying mucosa and the underlying vocal ligament. Vocal fold scarring is currently best treated by augmentation procedures, and atrophy may be compensated for by medialization thyroplasty or by adding bulk to the affected folds. Application of current knowledge of laryngeal histology and physiology is prerequisite to endoscopic surgical interventi